A subcutaneous infusion is the controlled introduction of larger quantities of fluid into the subcutaneous fatty tissue (subcutis). Subcutaneous infusions are used primarily in outpatient and inpatient care as well as in home care. The advantage of a subcutaneous infusion is that it is easy to administer. It does not have to be applied by a physician.
Subcutaneous immunoglobulin therapy offers patients a number of advantages. The subcutaneous infusion technique can be performed by the patient himself at home after intensive instruction by the physician. He no longer needs to visit the doctor or clinic for an infusion and can flexibly integrate the injections into his individual daily routine. Fewer days of absence from work, training or school, more time for family, hobbies and leisure activities significantly increase the quality of life.
At the beginning of subcutaneous immunoglobulin therapy, the patient must be intensively trained by healthcare professionals. If possible, the training should be carried out in a treatment center experienced with immunoglobulin therapy.
In subcutaneous Parkinson’s therapy, the drug is delivered directly under the skin (subcutaneously). The device ensures that the active ingredient used is delivered evenly. Those sites in the brain where dopamine docks are thus constantly stimulated.
Pump therapy is used primarily in the later stages of Parkinson’s disease, when treatment with tablets is no longer successful or when the disease already affects gastric activity or swallowing disorders are present and the medication can no longer be taken orally.
In this case, pump therapy can provide relief through the continuous delivery of the active ingredient and give sufferers back some of their quality of life.
Thalassemias are genetic disorders of hemoglubin formation in which there is a deficiency of certain protein chains of the hemoglobin molecule.